About Bluejay Diagnostics
Bluejay Diagnostics is a company based in Acton (United States) founded in 2015. Bluejay Diagnostics has raised $3.73 million across 7 funding rounds. The company has 7 employees as of December 31, 2024. Bluejay Diagnostics offers products and services including Symphony and Diagnostic Test Cartridge. Bluejay Diagnostics operates in a competitive market with competitors including OpGen, CytoVale, Avails Medical, SphingoTec and Abionic, among others.
- Headquarter Acton, United States
- Employees 7 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Bluejay Diagnostics, Inc.
-
Annual Revenue
Not available
-
Net Profit
-$7.72 M (USD)22.46as on Dec 31, 2024
-
EBITDA
-$6.97 M (USD)26.86as on Dec 31, 2024
-
Total Equity Funding
$3.73 M (USD)
in 7 rounds
-
Latest Funding Round
$4.5 M (USD), Post-IPO
Oct 09, 2025
-
Investors
Not available
-
Employee Count
7
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bluejay Diagnostics
Bluejay Diagnostics is a publicly listed company on the NASDAQ with ticker symbol BJDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bluejay Diagnostics
Bluejay Diagnostics offers a comprehensive portfolio of products and services, including Symphony and Diagnostic Test Cartridge.
Automated system for near-patient biomarker detection and analysis.
Single-use cartridge with integrated reagents for sample-to-result testing.
People of Bluejay Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Bluejay Diagnostics
Bluejay Diagnostics has successfully raised a total of $3.73M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4.5 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Bluejay Diagnostics
Investment portfolio details for Bluejay Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bluejay Diagnostics
Detailed financials for Bluejay Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bluejay Diagnostics Comparisons
Peer comparison for Bluejay Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bluejay Diagnostics
Bluejay Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, CytoVale, Avails Medical, SphingoTec and Abionic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Microfluidic-based biomarkers for the early detection of sepsis
|
|
| Locked | Locked | Locked |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| Locked | Locked | Locked |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic tools for allergy profiles are provided.
|
|
| Locked | Locked | Locked |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
|
Detailed competitors of Bluejay Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bluejay Diagnostics
Complete news archive for Bluejay Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bluejay Diagnostics
Bluejay Diagnostics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Bluejay Diagnostics is headquartered in Acton, United States.
Svetlana Dey is the current CEO of Bluejay Diagnostics.
Bluejay Diagnostics is a funded company, having raised a total of $3.73M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Bluejay Diagnostics is 7.
Bluejay Diagnostics was founded in 2015 and is headquartered in Acton, United States. Non-invasive point-of-care diagnostic solutions are developed within the healthcare sector, focusing on rapid testing methods. Operations center on creating assays that measure biomarkers in bodily fluids, such as IgE levels in tears for allergic conjunctivitis diagnosis. Services target medical professionals seeking accessible diagnostic tools, with activities conducted primarily in the U.S. market.
Bluejay Diagnostics's top competitors include CytoVale, Abionic and Avails Medical.
Bluejay Diagnostics offers Symphony and Diagnostic Test Cartridge.
Yes, Bluejay Diagnostics is publicly traded on NASDAQ under the ticker symbol BJDX.
The ticker symbol of Bluejay Diagnostics is BJDX on NASDAQ.